JOHNSON & JOHNSON (JNJ) vs Meta Platforms, Inc.(META)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | JNJ | META |
|---|---|---|
| Sector | Health Care | Information Technology |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $94.19B | $200.97B |
| Revenue growth (YoY) | ▲ 6.0% | ▲ 22.2% |
| Net income | $26.80B | $60.46B |
| Gross margin | 67.9% | — |
| Diluted EPS | $11.03 | $23.49 |
| Insider net (6 mo) | −40.8K sh · 6 sells · 0 buys | +614.1K sh · 95 sells · 0 buys |
| Institutional owners | 47 | 58 |
| Institutional value held | $294.77B | $694.95B |
| Next earnings (est.) | Around Oct 13, 2026 | Oct 28, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About JOHNSON & JOHNSON (JNJ)
Johnson & Johnson, incorporated in New Jersey in 1887, is a global healthcare holding company with approximately 138,200 full-time-equivalent employees engaged in the research, development, manufacture, and sale of a broad range of healthcare products.
About Meta Platforms, Inc. (META)
Meta Platforms, Inc. (formerly Facebook), a Delaware corporation, describes its mission as giving people the power to build community and bring the world closer together, with all products supporting a broader vision of helping build the metaverse.
Source: SEC EDGAR.